FDA Clearance Tracker · P130028-S031
Algovita Spinal Cord Stimulation System
Last checked: Nov 20, 2026Latest source record: May 5, 2020 (this decision)Source: openFDAMethods & limitations
Decided
May 5, 2020
Approved
Time to decision
182 days
Received Nov 5, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P130028-S031
- Device name
- Algovita Spinal Cord Stimulation System
- Applicant
- Nuvectra Corporation
- Applicant location
- Blaine, MN
- Received
- Nov 5, 2019
- Decided
- May 5, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P130028
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval use for the Algovita Clinician Programmer application and Nuvectra Bridge Communicator as per the letter dated May 5, 2020.
Source documents
Other decisions for Nuvectra Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130028 · Decided Nov 20, 2015 · 704 days after receipt
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.